Tristel plc
("Tristel" or the "Company")
Issue of Equity
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that, following the exercise of options by an employee, it has issued and allotted 16,500 new ordinary shares of 1 penny each in the Company ("Ordinary Shares"). Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 11 May 2018.
The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following the exercise of options, the Company's issued share capital consists of 43,184,133 Ordinary Shares. Accordingly, the figure of 43,184,133 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information please contact:Tristel plc
Paul Swinney, Chief Executive Officer Liz Dixon, Finance Director
Walbrook PR Ltd
Paul McManus Lianne CawthorneTel: 01638 721 500
Tel: 020 7933 8780 ortristel@walbrookpr.com
Mob: 07980 541 893
Mob: 07854 391 303
finnCap
Geoff Nash (Corporate Finance) Giles Rolls (Corporate Finance) Alice Lane (Corporate Broking)
Tel: 020 7220 0500
Attachments
- Original document
- Permalink
Disclaimer
Tristel plc published this content on 08 May 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 08 May 2018 15:19:10 UTC